The general objective of this study is to identify the predictive factors of recurrence after surgery for cervico-mental keloid of at least ≥ 10 cm and reaching the sternum. This is a prospective cohort study of 32 adult Congolese Negroid males who had previously undergone keloidectomy with immediate closure or keloidectomy followed by dressings and then skin grafting. The study covers the period from January 1, 2011, to April 30, 2023, with a follow-up of at least 18 months. The majority of patients (71.7%) were aged between 20 and 49 years. The etiology was traumatic (beard shaving, post-traumatic wounds) in 74.9%. The majority of lesions (68.9%) were between 11 and 20 years. In half of the cases (53%), patients consulted in the presence of the 2nd and 3rd recurrence. Half of the patients received less than 5 sessions of corticosteroid infiltrations, i.e., 59.3%. Half of the cases (56.2%) recurred 2 years after surgery and had a keloid size between 20 - 29 cm long. The most commonly performed type of surgery (71.8%) was intrascar keloidectomy directed healing and skin graft. Recurrence was observed more in keloidectomy and immediate closure (66.6%) than in keloidectomy + dressings and skin graft (34.3%). Keloidectomy and immediate closure were the sources of abscesses and suppurations in 88.8% of cases. The overall incidence of keloid recurrence is 13.0 (11.4 - 15.6) per 100 P-M. This incidence increases as the months go by. Predictive factors for keloid recurrence are post-surgery infection (31.3 per 100 P-M versus 1.8 per 100 P-M), size ≥ 30 cm (RR = 35.3 per 100 P-M) and a size of 20 - 29 cm (RR = 14.1 per 100 P-M), evolutionary duration of ≥ 10 years (RR = 23.0 per 100 P-M) and finally immediate simple suture (RR = 1 per 100 P-M). Protective predictive factors were keloidectomy + dressing + graft + corticosteroid therapy. Finally, the Kaplan Meir curve of patients according to secondary procedure performed after keloidectomy shows that the incidence of recurrence is significantly (Log-rank, p = 0.029) higher in patients whose secondary procedure performed is immediate closure (lC = 19.4 for P-M) compared to those whose secondary procedure is dressings and skin grafts (lC = 9.6 for P-M). It, therefore, emerges from this study that for large keloid scars of the chin and neck at least 10 cm long, intracranial surgery followed by dressings and skin grafts associated with corticosteroid infiltrations gives a low rate of recurrence.
Cite this paper
Kibadi-Kapay, A. and Mitila-Linda, H. (2025). Predictive Factors for Recurrence of Giant Cervical-Mental Keloid Scars in Adults. Open Access Library Journal, 12, e2769. doi: http://dx.doi.org/10.4236/oalib.1112769.
Ojeh, N., Bharatha, A., Gaur, U. and Forde, A.L. (2020) Keloids: Current and Emerging Therapies. Scars, Burns & Healing, 6.https://doi.org/10.1177/2059513120940499
Allah, K.C., Yéo, S., Kossoko, H., Assi Djè Bi Djè, V. and Richard Kadio, M. (2013) Cicatrices chéloïdes sur peau noire: Mythe ou réalité. Annales de Chirurgie Plastique Esthétique, 58, 115-122. https://doi.org/10.1016/j.anplas.2012.02.005
Ogawa, R. (2021) The Most Current Algorithms for the Treatment and Prevention of Hypertrophic Scars and Keloids: A 2020 Update of the Algorithms Published 10 Years Ago. Plastic & Re-constructive Surgery, 149, 79e-94e. https://doi.org/10.1097/prs.0000000000008667
Jaloux, C., Bertrand, B., Degardin, N., Casanova, D., Kerfant, N. and Philandrianos, C. (2017) Les cicatrices chéloïdes (deuxième partie): Arsenal et stratégie thérapeutique. Annales de Chirurgie Plastique Esthétique, 62, 87-96. https://doi.org/10.1016/j.anplas.2016.04.006
Peiffert, D., Chassagne, J.F., Pernot, M., et al. (1995) Chirurgie et curiethérapie des chéloïdes. Revue de Stomatologie et de Chirurgie Maxillo-Faciale, 96, 108-112.
Apfelberg, D.B., Maser, M.R., Dds, H.L., White, D. and Weston, J. (1984) Preliminary Results of Argon and Carbon Dioxide Laser Treatment of Keloid Scars. Lasers in Surgery and Medicine, 4, 283-290. https://doi.org/10.1002/lsm.1900040309
Escarmant, P., Zimmermann, S., Amar, A., et al. (1993) Le traitement de 783 cicatrices chéloïdes par irradiation interstitielle à l’iridium 192 après exérèse chirurgicale. International Journal of Ra-diation Oncology, Biology, Physics, 26, 108-112.
Huang, C., Liu, L., You, Z., Du, Y. and Ogawa, R. (2019) Managing Keloid Scars: From Radiation Therapy to Actual and Potential Drug Deliveries. International Wound Journal, 16, 852-859. https://doi.org/10.1111/iwj.13104
Mushegera, C.K. and Mbuyi-Muamba, J.M. (1998) épidémiologie des chéloïdes et des cicatrices hypertrophiques dans la population congolaise. Annales de l’Institut de Recherches en Sciences de la Santé, 1, 15-19.
Kibadi, K. (2021) Deuxième piercing auriculaire à but esthétique et apparition de cicatrices pathologiques chez les négroïdes: à propos de 172 observations dans une zone endémique de chéloïdes. Annales de Chirurgie Plastique Esthétique, 66, 42-51. https://doi.org/10.1016/j.anplas.2020.07.004
Kibadi, K., Muhota, D.K., Mudimisi, F.N., Mufasoni, S.M., Mukendi, Y.M.W., Mukendi, A.T., et al. (2012) Keloids: Epidemiological Aspects and Reasons for Refusal of Surgical Treatment in Kinshasa (Democratic Republic of Congo). Médecine et Santé Tropicales, 22, 182-186. https://doi.org/10.1684/mst.2012.0055
Lemperle, G., Schierle, J., Kitoga, K.E., Kassem-Trautmann, K., Sachs, C. and Dimmler, A. (2020) Keloids: Which Types Can Be Excised without Risk of Recurrence? A New Clinical Classification. Plastic and Reconstructive Surgery-Global Open, 8, e2582. https://doi.org/10.1097/gox.0000000000002582
Kibadi, K., Tsakala, T.M., Mputu-Yamaba, J.B., Kashongwe, M., Muyembe, T. and Impso, I. (2002) Essai thérapeutique de l’association chloramine-métronidazole-nitrofurandoïne. Médecine d’Afrique Noire, 49, 239-243.
Liu, R., Xiao, H., Wang, R., Li, W., Deng, K., Cen, Y., et al. (2022) Risk Factors Associated with the Progression from Keloids to Severe Keloids. Chinese Medical Journal, 135, 828-836. https://doi.org/10.1097/cm9.0000000000002093